US Patent 11077137 Method for treating diastolic heart failure by inhibiting galectin-3

Patent 11077137 was granted and assigned to Henry Ford Health System on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Henry Ford Health System

Current Assignee

Henry Ford Health System

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11077137

Patent Inventor Names

Hani N. Sabbah0

Date of Patent

August 3, 2021

Patent Application Number

20180123

Date Filed

January 23, 2018

Patent abstract

A method for treating diastolic heart failure is provided including identifying a subject having diastolic heart failure and administering a therapeutically effective amount of a galectin-3 inhibitor to the subject to at least partially alleviate a symptom of diastolic heart failure.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11077137 Method for treating diastolic heart failure by inhibiting galectin-3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API